| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |